Radiopharmaceuticals
We are the leader in Poland in the production of radiopharmaceuticals for PET-CT studies
National producer and distributor of radiopharmaceuticals
We are a manufacturer and distributor of radiopharmaceuticals for Positron Emission Tomography (PET), used in oncological, cardiological and neurological diagnostics.
We are a radiopharmaceutical wholesaler. We remain independent as a manufacturer as well as a supplier. We can provide radiopharmaceuticals to the PET/CT both in Poland and abroad.
The highest quality products
Our products are manufactured in accordance with GMP and national standards. Our employees are some of the most experienced in the sector.
Our guiding principle is quality. We apply it both for our products and for customer service.
Read more about how the activities related to sources of ionizing radiation impact human health and the environment.
Production of radiopharmaceuticals
The manufactures of radiopharmaceuticals take place in
Świętokrzyskie Centrum Onkologii (Holly Cross Cancer Center) in Kielce
It is one of the most important centers in Poland focused on the oncological care of patients offering diagnostic, treatment and rehabilitation services.
Military Medical Institute in Warsaw
Production plant in Mszczonów
In specially prepared and equipped rooms we conduct radioisotope manufacturing, synthesis and quality control.
Indications for use and information about medicinal products
| Product | Details | Action |
|---|---|---|
| Axumin | Positron emission tomography (PET) tracer for detection of prostate cancer recurrence suspected by elevated blood prostate specific antigen levels | Pobierz plik |
| FLT (18F) Synektik | Znacznik przeznaczony do określania lokalizacji nowotworów złośliwych, dzięki możliwości oznaczania komórek, w których zachodzą bardzo nasilone procesy podziału | Pobierz plik |
| Fludeoxyglucose (18F) Synektik | Tracer for use with positron emission tomography (PET) in oncological, cardiological, neurological, and infectious and inflammatory diseases diagnostic procedures | Pobierz plik |
| Fluorocholine (18F) Synektik | Tracer for use with positron emission tomography (PET) in detection of bone metastases of prostate cancer and hepatocellular carcinoma | Pobierz plik |
| GalliaPharm Ge-68/Ga-68 generator | Pharmaceutical product for obtaining the positron emitter Gallium (68) for production of labelled tracers (for example peptides) | Pobierz plik |
| Glunektik | Tracer for use with positron emission tomography (PET) in oncological, cardiological and neurological diagnostic procedures and infectious and inflammatory diseases | Pobierz plik |
| IASOdopa (is available by means of direct import procedure only) | Tracer for use with positron emission tomography (PET) in oncological and neurological diagnostic procedures | Pobierz plik |
| IASOglio | Tracer for use with positron emission tomography (PET) when enhanced amino acids consumption of sick organs or tissues is the diagnostic target | Pobierz plik |
| Natrii fluoridum (18F) Synektik | Tracer for use with positron emission tomography (PET) in diseases where abnormally altered osteogenic activity is the diagnostic target | Pobierz plik |
| Product | Details | Action |
|---|---|---|
| Axumin | Positron emission tomography (PET) tracer for detection of prostate cancer recurrence suspected by elevated blood prostate specific antigen levels | Pobierz plik |
| FLT (18F) Synektik | Znacznik przeznaczony do określania lokalizacji nowotworów złośliwych, dzięki możliwości oznaczania komórek, w których zachodzą bardzo nasilone procesy podziału | Pobierz plik |
| Fludeoxyglucose (18F) Synektik | Tracer for use with positron emission tomography (PET) in oncological, cardiological, neurological, and infectious and inflammatory diseases diagnostic procedures | Pobierz plik |
| Fluorocholine (18F) Synektik | Tracer for use with positron emission tomography (PET) in detection of bone metastases of prostate cancer and hepatocellular carcinoma | Pobierz plik |
| GalliaPharm Ge-68/Ga-68 generator | Pharmaceutical product for obtaining the positron emitter Gallium (68) for production of labelled tracers (for example peptides) | Pobierz plik |
| Glunektik | Tracer for use with positron emission tomography (PET) in oncological, cardiological and neurological diagnostic procedures and infectious and inflammatory diseases | Pobierz plik |
| IASOdopa (is available by means of direct import procedure only) | Tracer for use with positron emission tomography (PET) in oncological and neurological diagnostic procedures | Pobierz plik |
| IASOglio | Tracer for use with positron emission tomography (PET) when enhanced amino acids consumption of sick organs or tissues is the diagnostic target | Pobierz plik |
| Natrii fluoridum (18F) Synektik | Tracer for use with positron emission tomography (PET) in diseases where abnormally altered osteogenic activity is the diagnostic target | Pobierz plik |
Reporting of Adverse Reactions
This is the obligation of Marketing Authorization Holder to assure that any aspect which could impact the safety profile of authorized medicinal products is detected and assessed and that necessary measures are taken. This monitoring is called pharmacovigilance and requires collecting and managing data on the safety of medicines. It concerns in particual information about Adverse Reactions caused by the medicinal products.
For more information or to report a side effect, please click on the button below.
